Development of new basal insulin peglispro (LY2605541) ends in a disappointing result [0.03%]
新型基础胰岛素peglispro(LY2605541)开发折戟沉沙
Takahisa Hirose
Takahisa Hirose
Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report [0.03%]
日本糖尿病学会/日本癌学会糖尿病与癌症联合委员会报告第二部分
Atsushi Goto,Hiroshi Noto,Mitsuhiko Noda et al.
Atsushi Goto et al.
The Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer published its first report in July 2013 on the epidemiological assessment of the associations of diabetes with cancer risk/prognosis, ...
A large-scale observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 1 diabetes-JDCP study 2 [0.03%]
一项针对日本糖尿病并发症及其预防的现状展开的大规模观察性研究：1型糖尿病研究概要和基线资料-日本糖尿病并发症队列研究2
Rimei Nishimura,Kazuo Izumi,Yasuaki Hayashino et al.
Rimei Nishimura et al.
The JDCP study is a large-scale, prospective observational study designed to elucidate risk factors for diabetic complications as they become manifest in Japanese type 1 and 2 diabetic patients in the course of their observation and follow-...
Yuichi Makino,Masakazu Haneda
Yuichi Makino
Salicylic acid: old and new implications for the treatment of type 2 diabetes? [0.03%]
水杨酸：治疗2型糖尿病的旧药新意？
Graham Rena,Kei Sakamoto
Graham Rena
Efficacy of salicylic acid as a treatment for diabetes was first established well over a century ago. Antihyperglycaemic effects are thought to include improved peripheral insulin sensitivity and suppression of hepatic glucose production. F...